Crossject Company

Crossject is a French biopharmaceutical company that specializes in developing and commercializing innovative drug delivery systems. Their proprietary technology, Zeneo, enables the delivery of various therapeutics via an advanced needle-free injection system. With a focus on transforming the treatment landscape for severe acute conditions such as anaphylaxis, opioid overdose, and epilepsy, Crossject aims to improve patient outcomes and convenience. For more information about Crossject and its groundbreaking solutions, please visit their website.